Description
Combination of modified GRF(1-29) and ipamorelin for controlled receptor-signaling assays. Nominal contents: 10 mg per vial. Composition, identity, purity, and storage conditions must be verified against the lot-specific certificate of analysis before release. For laboratory research use only; not for human or veterinary use.






Reviews
There are no reviews yet.